From: Gut metabolites predict Clostridioides difficile recurrence
 | Recurrers N = 19 | Non-recurrers N = 34 | P value |
---|---|---|---|
Demographic data | |||
 Race | |||
  Black | 1 | 7 | 0.36 |
  Hispanic | 3 | 2 | |
  White | 15 | 25 | |
 Sex | |||
  Male | 5 | 13 | 0.55 |
  Female | 14 | 21 | |
 Age | |||
  Mean | 57.2 ± 17.2 | 58.4 ± 14.3 | 0.7 |
  Range | (22, 93) | (30, 87) | |
Clinical data | |||
 Body-mass index (BMI) | |||
  Mean | 28.3 ± 6.9 | 29.2 ± 9.3 | 0.87 |
  Range | (20.1, 45.1) | (19.4, 66.7) | |
 Test used for diagnosis | |||
  PCR | 4 | 17 | 0.046 |
  EIA toxin | 15 | 17 | |
 Initial treatment antibiotic used | |||
  Vancomycin | 11 | 27 | 0.12 |
  Metronidazole | 8 | 7 | |
 Prior PPI use | |||
  No | 11 | 17 | 0.77 |
  Yes | 8 | 17 |